We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$118B
AUM Growth
+$8.21B
Cap. Flow
+$1.08B
Cap. Flow %
0.91%
Top 10 Hldgs %
16.3%
Holding
2,665
New
135
Increased
1,412
Reduced
606
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 16.35%
2 Financials 15.6%
3 Healthcare 12.81%
4 Consumer Discretionary 10.96%
5 Communication Services 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBG
2251
DELISTED
Bill Barrett Corp
BBG
$211K ﹤0.01%
41,136
+14,336
+53% +$73.4K
BETR
2252
DELISTED
Amplify Snack Brands, Inc.
BETR
$210K ﹤0.01%
17,500
ICFI icon
2253
ICF International
ICFI
$1.46B
$210K ﹤0.01%
4,002
RMR icon
2254
The RMR Group
RMR
$325M
$209K ﹤0.01%
+3,531
New +$199K
CPLA
2255
DELISTED
Capella Education Company
CPLA
$209K ﹤0.01%
+2,699
New +$210K
MATX icon
2256
Matsons
MATX
$6.13B
$209K ﹤0.01%
+7,000
New +$198K
AEGN
2257
DELISTED
Aegion Corp
AEGN
$209K ﹤0.01%
+8,199
New +$206K
COBZ
2258
DELISTED
CoBiz Financial,Inc
COBZ
$208K ﹤0.01%
10,397
KERX
2259
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$208K ﹤0.01%
44,634
+5,577
+14% +$30.7K
BCRX icon
2260
BioCryst Pharmaceuticals
BCRX
$2.28B
$207K ﹤0.01%
42,185
LKFN icon
2261
Lakeland Financial Corp
LKFN
$1.56B
$207K ﹤0.01%
4,260
HCC icon
2262
Warrior Met Coal
HCC
$4.19B
$206K ﹤0.01%
+8,200
New +$206K
GNMK
2263
DELISTED
GenMark Diagnostics, Inc
GNMK
$206K ﹤0.01%
49,400
+26,000
+111% +$156K
USPH icon
2264
US Physical Therapy
USPH
$1.2B
$206K ﹤0.01%
+2,848
New +$194K
LMNX
2265
DELISTED
Luminex Corp
LMNX
$206K ﹤0.01%
+10,433
New +$217K
XNCR icon
2266
Xencor
XNCR
$1.5B
$205K ﹤0.01%
+9,369
New +$203K
JBSS icon
2267
John B. Sanfilippo & Son
JBSS
$967M
$203K ﹤0.01%
3,217
WIFI
2268
DELISTED
Boingo Wireless, Inc.
WIFI
$203K ﹤0.01%
+9,040
New +$207K
FLIC
2269
DELISTED
First of Long Island Corp
FLIC
$203K ﹤0.01%
7,127
PARR icon
2270
Par Pacific Holdings
PARR
$4.31B
$202K ﹤0.01%
10,498
BKE icon
2271
Buckle
BKE
$2.25B
$202K ﹤0.01%
+8,499
New +$167K
UFI icon
2272
UNIFI
UFI
$119M
$201K ﹤0.01%
+5,599
New +$203K
PLAB icon
2273
Photronics
PLAB
$1.79B
$200K ﹤0.01%
23,517
RUN icon
2274
Sunrun
RUN
$2.34B
$200K ﹤0.01%
33,848
+4,321
+15% +$24.8K
VHT icon
2275
Vanguard Health Care ETF
VHT
$18.1B
$199K ﹤0.01%
1,288
+19
+1% +$2.92K

Similar funds

UBS AM's Q4 2017 Portfolio in Review

As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
  • UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
  • UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
  • UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
  • UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
  • UBS AM opened 135 new positions and closed 93 in Q4 2017.
  • UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.